SLC39A9 and prostate carcinoma: (24) reported that the expression of ZIP9 was upregulated in breast and prostate cancer tissues, and androgen promoted the apoptosis of breast cancer MDAMB-468 cells and prostate cancer PC-3 cells through ZIP9.